Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 91 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 5 Breast Neoplasms 3 Neoplasms 2 Castration-resistant Prostate Cancer 2 Urinary Bladder Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Salivary Glands Tumors 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Oligometastatic Prostate Carcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoadjuvant Therapy 1 NSCLC Harboring NRG1 Fusion 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hyperaldosteronism 1 Cushing Syndrome 1 Carcinoma, Transitional Cell 1 Adrenocortical Carcinoma 1 Adenocarcinoma 1

Interventions

pembrolizumab 6 Mitotane 5 Cisplatin 5 cabozantinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Radiotherapy 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cytoreduction Surgical Procedures 2 milademetan 1 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Tamoxifen 1 Suramin 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × Abiraterone Acetate × Clear all

NCT03145285 2017-05-10

ABACUS

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Cushing Syndrome, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡